Tesa + Ipa 3 Month Results with Before After : r Tesamorelin Results from the 26 week Confirmatory, Phase 3 Trial of Tesamorelin (TH9507), a Growth Hormone Releasing Factor Analogue, in HIV Patients with Excess Abdominal Fat: A Multicenter, Double blind, Placebo controlled Study with 404 Randomized Patients FROM 208 Lb 172 Lb 24% 12.2% BODY FAT ZERO muscle lost Peptides have been phenomenal. After locking in nutrition, tracking macros, and training 5x week, this patient added CJC Ipamorelin + Tesamorelin Ipamorelin & Semax, peptide Semax